Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3)

Bengt Eriksson, Giancarlo Agnelli, Alexander Gallus, Michael Lassen, M Prins, Ronny Renfurm, Makoto Kashiwa, A Turpie

    Research output: Contribution to journalArticlepeer-review

    16 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3)'. Together they form a unique fingerprint.

    Medicine & Life Sciences